Contineum Therapeutics, Inc. (CTNM)
NASDAQ: CTNM · Real-Time Price · USD
14.25
-0.12 (-0.84%)
May 22, 2026, 10:28 AM EDT - Market open
Contineum Therapeutics Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
51
Market Cap
532.76M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | 50.00M | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Ginkgo Bioworks Holdings | 151.40M |
| Prothena Corporation | 57.94M |
| vTv Therapeutics | 36.84M |
| Ocugen | 4.47M |
| Prime Medicine | 4.03M |
| ProKidney | 889.00K |
CTNM News
- 2 hours ago - Contineum Therapeutics Touts PIPE-791 IPF Focus as Pain Data Hint at Wider Potential - MarketBeat
- 2 days ago - Contineum Therapeutics Transcript: RBC Capital Markets Global Healthcare Conference 2026 - Transcripts
- 6 days ago - Contineum Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 7 days ago - Contineum price target raised to $16 from $14 at Morgan Stanley - TheFly
- 9 days ago - Contineum Therapeutics to Present at the 2026 RBC Capital Markets Global Healthcare Conference - Business Wire
- 10 days ago - Contineum Therapeutics Announces Two Upcoming Posters at the American Thoracic Society (ATS) 2026 International Conference - Business Wire
- 16 days ago - Contineum Therapeutics Reports First-Quarter 2026 Financial Results; Affirms Key Clinical Development Milestones - Business Wire
- 16 days ago - Contineum Therapeutics Earnings release: Q1 2026 - Filings